Vanillin-induced amelioration of depression-like behaviors in rats by modulating monoamine neurotransmitters in the brain

Psychiatry Research

Volumn 225, Issue 3, 2015, Pages 509-514

  Xu, Jinyong ^a   Xu, Hui ^b   Liu, Yang ^c   He, Haihui ^d   Li, Guangwu ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Anhui College of Traditional Chinese Medicine   (China)

^c The First People's Hospital of Hefei City   (China)

^d UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Aromatherapy; Chronic unpredictable mild stress; Corticosterone; Major depressive disorder; Olfactory pathway; Ultrahigh performance liquid chromatography

Indexed keywords

CORTICOSTERONE; DOPAMINE; MONOAMINE NEUROTRANSMITTER; NEUROTRANSMITTER; SEROTONIN; SUCROSE; UNCLASSIFIED DRUG; VANILLIN; BENZALDEHYDE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; BODY WEIGHT; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; FORCED SWIM TEST; IMMOBILITY TIME; MALE; NEUROPROTECTION; NONHUMAN; OLFACTORY SYSTEM; PHENOTYPE; PHYSICAL PHENOMENA; RAT; SUCROSE PREFERENCE TEST; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; AROMATHERAPY; AROUSAL; DISEASE MODEL; DRUG EFFECTS; EMOTION; MAJOR DEPRESSION; METABOLISM; ODOR; OLFACTORY BULB; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SENSORY DEPRIVATION; SPRAGUE DAWLEY RAT;

ANIMALS; AROMATHERAPY; AROUSAL; BENZALDEHYDES; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; DOPAMINE; EMOTIONS; MALE; OLFACTORY BULB; OLFACTORY PATHWAYS; RATS; RATS, SPRAGUE-DAWLEY; SENSORY DEPRIVATION; SEROTONIN; SMELL;

EID: 84922937320     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.11.056     Document Type: Article

References (47)

1. Abraham, D.J., Harris, L.S., Meade, B.J., Munson, A.E., Swerdlow, P.S., Patrick, G.A., 1997. US patent 5668182-method of calming or sedating an animal with a hydroxyl benzaldehyde compound. (accessed on 27.03.2010). http://www.patentstorm.us/patents/5668182/description.html.
2. Almeida R.N., Motta S.C., Brito F.C., Catallani B., Leite J.R Anxiolytic like effects of rose oil inhalation on the elevated plus maze test in rats. Pharmacol. Biochem. Behav. 2004, 77:361-364.
3. Belmaker R.H., Agam G. Major depressive disorder. New Engl. J. Med. 2008, 358:55-68.
4. Benignus V.A., Prah J.D. Olfaction: anatomy, physiology and behavior. Environ. Health Perspect. 1982, 44:15-21.
5. Bozza T., Feinstein P., Zheng C., Mombaerts P. Odorant receptor expression defines functional units in the mouse olfactory system. J. Neurosci. 2002, 22:3033-3043.
6. Bradley B.F., Starkey N.J., Brown S.L., Lea R.W. Anxiolytic effects of Lavandula angustifolia odour on the Mongolian gerbil elevated plus maze. J. Ethnopharmacol. 2007, 111:517-525.
7. Buck L., Axel R. A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell 1991, 65:175-187.
8. Cavanagh H.M.A., Wilkinson J.M. Biological activities of lavender essential oil. Phytother. Res. 2002, 16:301-308.
9. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci. 2002, 23:238-245.
10. Dalvi A., Lucki I. Murine models of depression. Psychopharmacology 1999, 147:14-16.
11. Edge J. A pilot study addressing the effect of aromatherapy massage on mood, anxiety and relaxation in adult mental health. Complement. Ther. Nurs. Midwifery 2003, 9:90-97.
12. Hebb A.L.O., Zacharko R.M., Dominguez H., Trudel F., Laforest S., Drolet G. Odor-induced variation in anxiety-like behavior in mice is associated with discrete and differential effects on mesocorticolimbic cholecystokinin mRNA expression. Neuropsychopharmacology 2002, 27:744-755.
13. Herz R. Aromatherapy facts and fictions: a scientific analysis of olfactory effects on mood, physiology and behaviour. Int. J. Neurosci. 2009, 119:263-290.
14. Ho K., Yazan L.S., Ismail N., Ismail M. Apoptosis and cell cycle arrest of human colorectal cancer cell line HT-29 induced by vanillin. Cancer Epidemiol. 2009, 33:155-160.
15. Ho K., Yazan L.S., Ismail N., Ismail M. Toxicology study of vanillin on rats via oral and intra-peritoneal administration. Food Chem. Toxicol. 2011, 49:25-30.
16. Jaako-Movits K., Zharkovsky T., Pedersen M., Zharkovsky A. Decreased hippocampal neurogenesis following olfactory bulbectomy is reversed by repeated citalopram administration. Cell. Mol. Neurobiol. 2006, 26:1557-1568.
17. Jesberger J.A., Richardson J.S. Brain output dysregulation induced by olfactory bulbectomy: an approximation in the rat of major depressive disorder in humans?. Int. J. Neurosci. 1988, 38:241-265.
18. Komiya M., Takachi T., Harada E. Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice. Behav. Brain Res. 2006, 172:240-249.
19. Komori T., Fujiwara R., Tanida M., Nomura J. Effects of citrus fragrance on immune function and depressive state. Neuroimunomodulat 1995, 2:174-180.
20. Komori T., Fujiwara R., Tanida M., Nomura J. Potential antidepressant effects of lemon odor in rats. Eur. Neuropsychopharmacol. 1995, 5:477-480.
21. Lehrner J., Marwinski G., Lehr S., Johren P., Deecke L. Ambient odor of orange and lavender reduce anxiety and improve mood in a dental office. Physiol. Behav. 2005, 86:92-95.
22. Mandairon N., Poncelet J., Bensafi M., Didier A. Humans and mice express similar olfactory preferences. PLoS One 2009, 4:e4209.
23. Matsukawa M., Imada M., Murakami T., Aizawa S., Sato T. Rose odor can innately counteract predator odor. Brain Res. 2011, 1381:117-123.
24. Megan E.B., Lucianne G., Ronald S.O., Herman G.M.W., Berend O. Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats. Biol. Psychiatry 2007, 61:990-995.
25. Motomura N., Sakurai A., Yotsuya Y. Reduction of mental stress with lavender odorant. Percep. Motor Skills 2001, 93:713-718.
26. Muscat R., Sampson D., Willner P. Dopaminergic mechanism of imipramine action in an animal model of depression. Biol. Psychiatry 1990, 28:223-230.
27. Nestler E.J., Barrot M., Dileone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
28. Papp M., Willner P., Muscat R. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology 1991, 104:255-259.
29. Pause B.M., Miranda A., Göder R., Aldenhoff J.B., Ferstl R. Reduced olfactory performance in patients with major depression. J. Psychiatr. Res. 2001, 35:271-277.
30. Pompili M., Rihmer Z., Innamorati M., Lester D., Girardi P., Tatarelli R. Assessment and treatment of suicide risk in bipolar disorders. Expert Rev. Neurother. 2009, 9:109-136.
31. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 1978, 47:379-391.
32. Rolls E.T. Convergence of sensory systems in the orbitofrontal cortex in primates and brain design for emotion. Anat. Rec. A: Discov. Mol. Cell. Evol. Biol. 2004, 281:1212-1225.
33. Royet J.P., Plailly J., Delon-Martin C., Kareken D.A., Segebarth C. fMRI of emotional responses to odors: influence of hedonic valence and judgment, handedness, and gender. Neuroimage 2003, 20:713-728.
34. Sa M., Ying L., Tang A.G., Xiao L.D., Ren Y.P. Simultaneous determination of tyrosine, tryptophan and 5-hydroxytryptamine in serum of MDD patients by high performance liquid chromatography with fluorescence detection. Clin. Chim. Acta 2012, 413:973-977.
35. Seubert J., Rea A.F., Loughead J., Habel U. Mood induction with olfactory stimuli reveals differential affective responses in males and females. Chem. Senses 2009, 34:77-84.
36. Stöcker T., Kellermann T., Schneider F., Habel U., Amunts K., Pieperhoff P., Zilles K., Shah N.J. Dependence of amygdala activation on echo time: results from olfactory fMRI experiments. Neuroimage 2006, 30:151-159.
37. Strome E.M., Wheler G.H., Higley J.D., Loriaux D.L., Suomi S.J., Doudet D.J. Intracerebroventricular corticotropin-releasing factor increases limbic glucose metabolism and has social context-dependent behavioral effects in nonhuman primates. Proc. Natl. Acad. Sci. 2002, 99:15749-15754.
38. Thiessen D., Rice M. Mammalian scent gland marking and social behavior. Psychol. Bull. 1976, 83:505-539.
39. Umezu T., Ito H., Nagano K., Yamakoshi M., Oouchi H., Sakaniwa M., Morita M. Anticonflict effects of rose oil and identification of its active constituents. Life Sci. 2002, 72:91-102.
40. Weier K.M., Beal M.W. Complementary therapies as adjuncts in the treatment of postpartum depression. J. Midwifery Women's Health 2004, 49:96-104.
41. Willner P., Muscat R., Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci. Biobehav. Re.v 1992, 16:525-534.
42. Wu L.M., Han H., Wang Q.N., Hou H.L., Tong H., Yan X.B., Zhou J.N. Mifepristone repairs region-dependent alteration of synapsin I in hippocampus in rat model of depression. Neuropsychopharmacology 2007, 32:2500-2510.
43. Xu Y., Ku B.S., Yao H.Y., Lin Y.H., Ma X., Zhang Y.H., Li X.J. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol. Biochem. Behav. 2005, 82:200-206.
44. Zald D.H., Pardo J.V. Emotion, olfaction, and the human amygdala: amygdale activation during aversive olfactory stimulation. Proc. Natl. Acad. Sci. USA 1997, 94:4119-4124.
45. Zald D.H. The human amygdala and the emotional evaluation of sensory stimuli. Brain Res. Rev. 2003, 41:88-123.
46. Zalsman G., Braun M., Arendt M., Grunebaum M.F., Sher L., Burke A.K., Brent D.A., Chaudhury S.R., Mann J.J., Oquendo M.A. A comparison of the medical lethality of suicide attempts in bipolar and major depressive disorders. Bipolar Disord. 2006, 8:558-565.
47. Zhao Y.Y., Liu L.Y., Han Y.Y., Bai J., Du G.L., Gao Q. Simultaneous detection of 8 monoamine neurotransmitters in the different sections of mouse brains by high performance liquid chromatography with fluorescence detection. Chin J Chromatogr. 2011, 29:146-151.